The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
We retrospectively reviewed the outcome and 7 prognostic factors (sex, age, stage, histologic type, chemotherapy, dose and response) of 167 patients with non-small cell lung radiotherapy on primary site more than 40 Gy between 1984 and 1991. The 2-year overall survival rate and MST were 22% and 13.4 months. Stage I, II and adenocarcinoma are favorable prognostic factors by univariate analysis, 40...
A retrospective analysis was performed to investigate the effect of Coenzyme Q 10 and azelastin on protecting radiation pneumonitis in patients with lung cancer. Twenty patients were administered Coenzyme Q 10 and azelastin every day during and after radiotherapy for 6 months. Historical controls of 20 patients were irradiated without administration of drugs. According...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.